Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Thymoma × Everolimus × Clear all

Sponsor

Conditions

Breast Neoplasms 41 Carcinoma, Renal Cell 31 Neoplasms 18 Kidney Neoplasms 17 Neuroendocrine Tumors 16 Neoplasm Metastasis 13 Tuberous Sclerosis 10 Prostatic Neoplasms 8 Carcinoma 8 Lymphoma, Mantle-Cell 7 Lymphoma, Large B-Cell, Diffuse 7 Hodgkin Disease 7 Glioma 7 Glioblastoma 7 Astrocytoma 7 Waldenstrom Macroglobulinemia 6 Triple Negative Breast Neoplasms 6 Recurrence 6 Lymphoma 6 Head and Neck Neoplasms 6 Stomach Neoplasms 5 Ovarian Neoplasms 5 Colorectal Neoplasms 5 Carcinoma, Neuroendocrine 5 Brain Neoplasms 5 Sezary Syndrome 4 Sarcoma 4 Precursor Cell Lymphoblastic Leukemia-Lymphoma 4 Pancreatic Neoplasms 4 Mycosis Fungoides 4

Interventions

Taxes 2 Sunitinib 2 Paclitaxel 2 N,1,4,4-tetramethyl-8-((4-(4-methylpiperazin-1-yl)phenyl)amino)-4,5-dihydro-1H-pyrazolo(4,3-h)quinazoline-3-carboxamide 2 Carboplatin 2 vorolanib 1 selinexor 1 saracatinib 1 pembrolizumab 1 epacadostat 1 belinostat 1 amrubicin 1 Thymectomy 1 Robotic Surgical Procedures 1 Ramucirumab 1 Prednisone 1 Prednisolone 1 Pemetrexed 1 Nivolumab 1 NVP-BKM120 1 MK 2206 1 Lapatinib 1 Fentanyl 1 Erlotinib Hydrochloride 1 Doxepin 1 AZD 6244 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡